CRBU Stock Price
Caribou Biosciences, Inc.
CRBU stock price is $0.46 (-2.11% on the day), giving Caribou Biosciences, Inc. a market cap of $49.33M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
CRBU Stock Overview
- Price
- $0.46
- Previous close
- $0.47
- Open
- $0.48
- Market cap
- $49.33M
- P/E ratio
- -0.3
- 52-week range
- $0.44 - $3.54
- 1-year price target
- $5.60
- Sector
- Healthcare
- Industry
- Biotechnology
- Exchange
- NGS
- MarketXLS Rank
- 38
About Caribou Biosciences, Inc.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and autoimmune diseases in the United States and internationally. The company's lead product candidate include CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma, refractory systemic lupus erythematosus, lupus nephritis, and extrarenal lupus. It also develops CB-011, an anti-BCMA allogeneic CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma; and CB-012, an allogeneic anti-CD371 CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory acute myeloid leukemia. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRBU | $0.46 | -2.1% | 3.70M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Caribou Biosciences, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW